Cancer Powered by Trendolizer

The Wall Street Journal | Roche Holding said its immunotherapy drug Tecentriq slowed...

Trending story found on www.facebook.com
The Wall Street Journal | Roche Holding said its immunotherapy drug Tecentriq slowed...
Roche Holding said its immunotherapy drug Tecentriq slowed the progression of lung cancer and helped patients live longer in a late-stage study, bolstering the Swiss drugmaker’s defense against a wave of cut-price competition to its top-selling medicines.
[Source: www.facebook.com] [ Comments ] [See why this is trending]

Trend graph:

Comments